1. Home
  2. EVOK vs CAPS Comparison

EVOK vs CAPS Comparison

Compare EVOK & CAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • CAPS
  • Stock Information
  • Founded
  • EVOK 2007
  • CAPS 1987
  • Country
  • EVOK United States
  • CAPS United States
  • Employees
  • EVOK N/A
  • CAPS N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • CAPS
  • Sector
  • EVOK Health Care
  • CAPS
  • Exchange
  • EVOK Nasdaq
  • CAPS NYSE
  • Market Cap
  • EVOK 7.7M
  • CAPS 7.4M
  • IPO Year
  • EVOK 2013
  • CAPS N/A
  • Fundamental
  • Price
  • EVOK $4.43
  • CAPS $1.60
  • Analyst Decision
  • EVOK
  • CAPS
  • Analyst Count
  • EVOK 0
  • CAPS 0
  • Target Price
  • EVOK N/A
  • CAPS N/A
  • AVG Volume (30 Days)
  • EVOK 7.2M
  • CAPS 94.2K
  • Earning Date
  • EVOK 08-12-2025
  • CAPS 04-02-2025
  • Dividend Yield
  • EVOK N/A
  • CAPS N/A
  • EPS Growth
  • EVOK N/A
  • CAPS N/A
  • EPS
  • EVOK N/A
  • CAPS N/A
  • Revenue
  • EVOK $11,594,083.00
  • CAPS $43,416,000.00
  • Revenue This Year
  • EVOK $57.82
  • CAPS $7.87
  • Revenue Next Year
  • EVOK $59.12
  • CAPS N/A
  • P/E Ratio
  • EVOK N/A
  • CAPS N/A
  • Revenue Growth
  • EVOK 89.89
  • CAPS N/A
  • 52 Week Low
  • EVOK $1.94
  • CAPS $1.30
  • 52 Week High
  • EVOK $12.32
  • CAPS $16.18
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 53.72
  • CAPS N/A
  • Support Level
  • EVOK $4.26
  • CAPS N/A
  • Resistance Level
  • EVOK $4.73
  • CAPS N/A
  • Average True Range (ATR)
  • EVOK 0.73
  • CAPS 0.00
  • MACD
  • EVOK -0.07
  • CAPS 0.00
  • Stochastic Oscillator
  • EVOK 25.95
  • CAPS 0.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About CAPS CAPSTONE HOLDING CORP

Capstone Holding Corp is a building products distribution network. The existing network is comprised of Instone, a distributor of thin veneer stone and related masonry products in the United States, serving both residential and commercial construction markets. The company's product offering includes manufactured and natural stone products, supported by a distribution network. The company's current products include stone veneer, landscape stone, and modular masonry fireplaces.

Share on Social Networks: